RMC No. 122-2020: VAT-Exempt Drugs List Clarified by FDA Based on Generic Names and Salt Forms

RMC No. 122-2020 clarifies VAT-exempt drug treatment using FDA-listed generic names or INNs, including salt forms, for medicine sellers and buyers. Businesses selling, importing, purchasing, or accounting for medicines covered by the VAT-exempt drug rules must review whether their products fall within the clarified FDA list, because the exemption is determined by the International Non-Proprietary […]